Business Type: Manufacturer, Trading Company, Distributor/Wholesaler
Employees Total 5
Annual Revenue US$2.5 Million - US$5 Million
Acalabrutinib is a medication used to treat a type of non-Hodgkin lymma known as mantle lymma. Specifically it is for people who had previously been treated with another therapy.
Signup today to claim your Discount. Get Started
before it's too late!
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok